Skip to content

Inventories at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$13.27M-9.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$32.98M+734%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$5.56M-51.7%
LQD
Liquidia CorporationLQDA
$28.51M+2,013%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$34.93M+76.6%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$25.52M+13.8%

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.58B+128%

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0.0×
Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's inventories?
Kiniksa Pharmaceuticals International, plc (KNSA) reported inventories of $73.14M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's inventories changed year-over-year?
Kiniksa Pharmaceuticals International, plc's inventories increased by 231.4% year-over-year, from $22.07M to $73.14M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.